• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

使用人工智能的肿瘤疾病决策支持系统的应用与准确性：一项系统评价和荟萃分析

Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis.

作者信息

Oehring Robert, Ramasetti Nikitha, Ng Sharlyn, Roller Roland, Thomas Philippe, Winter Axel, Maurer Max, Moosburner Simon, Raschzok Nathanael, Kamali Can, Pratschke Johann, Benzing Christian, Krenzien Felix

机构信息

Department of Surgery, Charité - Universitätsmedizin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Speech and Language Technology Lab, German Research Center for Artificial Intelligence (DFKI), Berlin, Germany.

出版信息

Front Oncol. 2023 Oct 4;13:1224347. doi: 10.3389/fonc.2023.1224347. eCollection 2023.

DOI:10.3389/fonc.2023.1224347
PMID:37860189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10584147/
Abstract

BACKGROUND

For therapy planning in cancer patients multidisciplinary team meetings (MDM) are mandatory. Due to the high number of cases being discussed and significant workload of clinicians, Clinical Decision Support System (CDSS) may improve the clinical workflow.

METHODS

This review and meta-analysis aims to provide an overview of the systems utilized and evaluate the correlation between a CDSS and MDM.

RESULTS

A total of 31 studies were identified for final analysis. Analysis of different cancers shows a concordance rate (CR) of 72.7% for stage I-II and 73.4% for III-IV. For breast carcinoma, CR for stage I-II was 72.8% and for III-IV 84.1%, P≤ 0.00001. CR for colorectal carcinoma is 63% for stage I-II and 67% for III-IV, for gastric carcinoma 55% and 45%, and for lung carcinoma 85% and 83% respectively, all P>0.05. Analysis of SCLC and NSCLC yields a CR of 94,3% and 82,7%, P=0.004 and for adenocarcinoma and squamous cell carcinoma in lung cancer a CR of 90% and 86%, P=0.02.

CONCLUSION

CDSS has already been implemented in clinical practice, and while the findings suggest that its use is feasible for some cancers, further research is needed to fully evaluate its effectiveness.

摘要

背景

对于癌症患者的治疗规划，多学科团队会议（MDM）是必不可少的。由于讨论的病例数量众多以及临床医生的工作量巨大，临床决策支持系统（CDSS）可能会改善临床工作流程。

方法

本综述和荟萃分析旨在概述所使用的系统，并评估CDSS与MDM之间的相关性。

结果

共确定31项研究进行最终分析。对不同癌症的分析显示，I-II期的一致性率（CR）为72.7%，III-IV期为73.4%。对于乳腺癌，I-II期的CR为72.8%，III-IV期为84.1%，P≤0.00001。结直肠癌I-II期的CR为63%，III-IV期为67%；胃癌分别为55%和45%；肺癌分别为85%和83%，所有P>0.05。对小细胞肺癌（SCLC）和非小细胞肺癌（NSCLC）的分析得出CR分别为94.3%和82.7%，P = 0.004；对肺癌中的腺癌和鳞状细胞癌分析得出CR分别为90%和86%，P = 0.02。

结论

CDSS已在临床实践中得到应用，虽然研究结果表明其对某些癌症的使用是可行的，但仍需要进一步研究以全面评估其有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/46078e64f147/fonc-13-1224347-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/15902f93695b/fonc-13-1224347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/6eaf3a5d6377/fonc-13-1224347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/55b87a52a7d8/fonc-13-1224347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/7574667e1e9e/fonc-13-1224347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/82d17a297f21/fonc-13-1224347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/984f47dba864/fonc-13-1224347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/fb468df56b41/fonc-13-1224347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/080efac83511/fonc-13-1224347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/d87aa8eebdfe/fonc-13-1224347-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/9b95d3cf5b22/fonc-13-1224347-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/46078e64f147/fonc-13-1224347-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/15902f93695b/fonc-13-1224347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/6eaf3a5d6377/fonc-13-1224347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/55b87a52a7d8/fonc-13-1224347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/7574667e1e9e/fonc-13-1224347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/82d17a297f21/fonc-13-1224347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/984f47dba864/fonc-13-1224347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/fb468df56b41/fonc-13-1224347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/080efac83511/fonc-13-1224347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/d87aa8eebdfe/fonc-13-1224347-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/9b95d3cf5b22/fonc-13-1224347-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be6e/10584147/46078e64f147/fonc-13-1224347-g011.jpg

相似文献

1
Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis.使用人工智能的肿瘤疾病决策支持系统的应用与准确性：一项系统评价和荟萃分析
Front Oncol. 2023 Oct 4;13:1224347. doi: 10.3389/fonc.2023.1224347. eCollection 2023.
2
Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board.人工智能与肺癌治疗决策：与多学科肿瘤委员会建议的一致性
Transl Lung Cancer Res. 2020 Jun;9(3):507-514. doi: 10.21037/tlcr.2020.04.11.
3
Concordance of a decision algorithm and multidisciplinary team meetings for patients with liver cancer-a study protocol for a randomized controlled trial.肝癌患者决策算法与多学科团队会议的一致性：一项随机对照试验研究方案。
Trials. 2023 Sep 9;24(1):577. doi: 10.1186/s13063-023-07610-8.
4
Assessing the decision quality of artificial intelligence and oncologists of different experience in different regions in breast cancer treatment.评估不同地区不同经验的人工智能和肿瘤学家在乳腺癌治疗中的决策质量。
Front Oncol. 2023 Jun 9;13:1152013. doi: 10.3389/fonc.2023.1152013. eCollection 2023.
5
Looking through the eyes of the multidisciplinary team: the design and clinical evaluation of a decision support system for lung cancer care.从多学科团队的视角审视：肺癌护理决策支持系统的设计与临床评估
Transl Lung Cancer Res. 2020 Aug;9(4):1422-1432. doi: 10.21037/tlcr-19-441.
6
Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Watson for Oncology 与乳腺癌治疗推荐：与专家多学科肿瘤委员会的一致性。
Ann Oncol. 2018 Feb 1;29(2):418-423. doi: 10.1093/annonc/mdx781.
7
Artificial Intelligence in Decision-Making for Colorectal Cancer Treatment Strategy: An Observational Study of Implementing Watson for Oncology in a 250-Case Cohort.人工智能在结直肠癌治疗策略决策中的应用：对250例病例队列实施肿瘤学沃森系统的观察性研究
Front Oncol. 2021 Feb 4;10:594182. doi: 10.3389/fonc.2020.594182. eCollection 2020.
8
Comparison of an oncology clinical decision-support system's recommendations with actual treatment decisions.比较肿瘤学临床决策支持系统的建议与实际治疗决策。
J Am Med Inform Assoc. 2021 Mar 18;28(4):832-838. doi: 10.1093/jamia/ocaa334.
9
A Clinical Decision Support System for Sleep Staging Tasks With Explanations From Artificial Intelligence: User-Centered Design and Evaluation Study.具有人工智能解释的睡眠分期任务临床决策支持系统：以用户为中心的设计和评估研究。
J Med Internet Res. 2022 Jan 19;24(1):e28659. doi: 10.2196/28659.
10
Effect of a computerized decision support system on the treatment approach of stage III or IV pressure injury in patients with spinal cord injury: a feasibility study.计算机化决策支持系统对脊髓损伤患者 III 期或 IV 期压力性损伤治疗方法的影响：一项可行性研究。
BMC Health Serv Res. 2023 Jan 31;23(1):103. doi: 10.1186/s12913-023-09045-y.

引用本文的文献

1
Artificial intelligence as a predictive tool for gastric cancer: Bridging innovation, clinical translation, and ethical considerations.人工智能作为胃癌的预测工具：连接创新、临床转化与伦理考量。
World J Gastrointest Oncol. 2025 May 15;17(5):103275. doi: 10.4251/wjgo.v17.i5.103275.
2
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.人工智能在肺癌临床应用的全面综述
Cancers (Basel). 2025 Mar 4;17(5):882. doi: 10.3390/cancers17050882.
3
Artificial Intelligence in Cardiac Surgery: Transforming Outcomes and Shaping the Future.

本文引用的文献

1
Watson for oncology decision system for treatment consistency study in breast cancer.沃森肿瘤学决策系统在乳腺癌治疗一致性研究中的应用。
Clin Exp Med. 2023 Sep;23(5):1649-1657. doi: 10.1007/s10238-022-00896-z. Epub 2022 Sep 22.
2
Cancer multidisciplinary team meetings: impact of logistical challenges on communication and decision-making.癌症多学科团队会议：后勤挑战对沟通和决策的影响。
BJS Open. 2022 Jul 7;6(4). doi: 10.1093/bjsopen/zrac093.
3
Using guideline-based clinical decision support in oncological multidisciplinary team meetings: A prospective, multicenter concordance study.
心脏外科手术中的人工智能：改变手术结果，塑造未来。
Clin Pract. 2025 Jan 14;15(1):17. doi: 10.3390/clinpract15010017.
4
The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review.利用人工智能优化临床决策支持系统生成的用药提醒：范围综述。
J Am Med Inform Assoc. 2024 May 20;31(6):1411-1422. doi: 10.1093/jamia/ocae076.
在肿瘤多学科团队会议中使用基于指南的临床决策支持：一项前瞻性、多中心一致性研究。
Int J Qual Health Care. 2022 Mar 19;34(1). doi: 10.1093/intqhc/mzac007.
4
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience.乳腺癌化疗中Watson肿瘤学系统的一致性评估：中国首例经验
Transl Cancer Res. 2019 Apr;8(2):389-401. doi: 10.21037/tcr.2019.01.34.
5
Machine-learning algorithm to predict multidisciplinary team treatment recommendations in the management of basal cell carcinoma.机器学习算法预测基底细胞癌多学科团队治疗建议。
Br J Cancer. 2022 Mar;126(4):562-568. doi: 10.1038/s41416-021-01506-7. Epub 2021 Sep 1.
6
Effect of multidisciplinary team care on survival of oesophageal cancer patients: a retrospective nationwide cohort study.多学科团队护理对食管癌患者生存的影响：一项回顾性全国队列研究。
Sci Rep. 2021 Jun 24;11(1):13243. doi: 10.1038/s41598-021-92618-w.
7
The ever-increasing importance of cancer as a leading cause of premature death worldwide.癌症作为全球范围内导致过早死亡的主要原因，其重要性日益增加。
Cancer. 2021 Aug 15;127(16):3029-3030. doi: 10.1002/cncr.33587. Epub 2021 Jun 4.
8
The cancer multidisciplinary team meeting: in need of change? History, challenges and future perspectives.癌症多学科团队会议：是否需要变革？历史、挑战与未来展望。
BJU Int. 2021 Sep;128(3):271-279. doi: 10.1111/bju.15495. Epub 2021 Jun 28.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
10
Conversion of a colorectal cancer guideline into clinical decision trees with assessment of validity.将一项结直肠癌指南转化为具有有效性评估的临床决策树。
Int J Qual Health Care. 2021 Apr 3;33(2). doi: 10.1093/intqhc/mzab051.